Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevelamer Carbonate TID in Hyperphosphatemic CKD Not on Dialysis
NCT00681941Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jan 2006
- Primary completion
- Jan 2007
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of sevelamer carbonate in hyperphosphatemia, sponsored by Sanofi. Started Jan 2006; status: completed.
02
Drugs
sevelamer carbonate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT00681941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00681941.